Molecular Biology and Pharmacology of PDE-5-Inhibitor Therapy for Erectile Dysfunction
Authors:
Open Access
- 12 November 2003
- journal article
- review article
- Published by Wiley in Journal of Andrology
- Vol. 24 (S6) , S38-S41
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- [3H]Sildenafil Binding to Phosphodiesterase-5 Is Specific, Kinetically Heterogeneous, and Stimulated by cGMPMolecular Pharmacology, 2003
- PHARMACOLOGY OF PHOSPHODIESTERASE‐5 INHIBITORSInternational Journal Of Clinical Practice, 2002
- Phosphorylation of phosphodiesterase‐5 by cyclic nucleotide‐dependent protein kinase alters its catalytic and allosteric cGMP‐binding activitiesEuropean Journal of Biochemistry, 2000
- Cyclic GMP Phosphodiesterase-5: Target of SildenafilJournal of Biological Chemistry, 1999
- Effects of sildenafil, a type‐5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitroBritish Journal of Urology, 1997